Related Experiment Video
Updated: Dec 15, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Assembly and regulation of the chlorhexidine-specific efflux pump AceI
Jani Reddy Bolla1, Anna C Howes1, Francesco Fiorentino1
1Physical and Theoretical Chemistry Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3QZ, United Kingdom.
Abstract:
Few antibiotics are effective against Acinetobacter baumannii, one of the most successful pathogens responsible for hospital-acquired infections. Resistance to chlorhexidine, an antiseptic widely used to combat A. baumannii, is effected through the proteobacterial antimicrobial compound efflux (PACE) family. The prototype membrane protein of this family, AceI (Acinetobacter chlorhexidine efflux protein I), is encoded for by the aceI gene and is under the transcriptional control of AceR (Acinetobacter chlorhexidine efflux protein regulator), a LysR-type transcriptional regulator (LTTR) protein. Here we use native mass spectrometry to probe the response of AceI and AceR to chlorhexidine assault. Specifically, we show that AceI forms dimers at high pH, and that binding to chlorhexidine facilitates the functional form of the protein. Changes in the oligomerization of AceR to enable interaction between RNA polymerase and promoter DNA were also observed following chlorhexidine assault. Taken together, these results provide insight into the assembly of PACE family transporters and their regulation via LTTR proteins on drug recognition and suggest potential routes for intervention.
Insights
This study reveals how Acinetobacter baumannii develops resistance to chlorhexidine. Understanding the AceI efflux pump and AceR regulator
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Acinetobacter baumannii is a major cause of hospital-acquired infections.
- Limited effective antibiotics necessitate understanding resistance mechanisms.
- The PACE (proteobacterial antimicrobial compound efflux) family mediates resistance, with AceI as a key efflux protein.
Purpose of the Study:
- To investigate the molecular mechanisms of chlorhexidine resistance in Acinetobacter baumannii.
- To elucidate the role of the AceI efflux protein and AceR regulator in response to chlorhexidine.
- To provide insights into the assembly and regulation of PACE family transporters.
Main Methods:
- Native mass spectrometry was employed to analyze AceI and AceR.
- The study examined protein oligomerization states under various conditions.
- The interaction of AceR with DNA and RNA polymerase was investigated.
Main Results:
- AceI (Acinetobacter chlorhexidine efflux protein I) forms dimers at high pH.
- Chlorhexidine binding promotes the functional conformation of AceI.
- Chlorhexidine exposure induced changes in AceR (Acinetobacter chlorhexidine efflux protein regulator) oligomerization, facilitating RNA polymerase-promoter DNA interaction.
Conclusions:
- The findings illuminate the structural and regulatory mechanisms of PACE transporters.
- Drug recognition by AceR and AceI is crucial for chlorhexidine resistance.
- This research suggests potential targets for combating Acinetobacter baumannii infections.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Drug Elimination by Renal Route: Tubular Secretion
Hand hygiene
Hand washing...
Hepatic Drug Clearance: Role of Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Renal Drug Excretion: Tubular Secretion

